Dark Forest Capital Management LP Takes Position in Integer Holdings Co. (NYSE:ITGR)

Dark Forest Capital Management LP bought a new position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,532 shares of the medical equipment provider's stock, valued at approximately $336,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Blue Trust Inc. raised its stake in Integer by 4.4% during the 4th quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock valued at $220,000 after purchasing an additional 71 shares during the period. Arizona State Retirement System grew its stake in Integer by 0.9% during the 4th quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider's stock valued at $1,290,000 after acquiring an additional 84 shares in the last quarter. HighPoint Advisor Group LLC increased its holdings in shares of Integer by 6.4% in the 4th quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider's stock valued at $234,000 after purchasing an additional 101 shares during the period. Norden Group LLC boosted its holdings in shares of Integer by 7.0% during the fourth quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider's stock worth $221,000 after purchasing an additional 109 shares during the period. Finally, Corient Private Wealth LLC lifted its position in Integer by 6.4% in the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider's stock worth $261,000 after buying an additional 118 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

Integer Stock Performance

Integer stock traded up $0.05 during mid-day trading on Friday, reaching $125.64. The company had a trading volume of 569,808 shares, compared to its average volume of 352,261. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62. The company has a 50 day moving average of $118.89 and a 200-day moving average of $130.14. Integer Holdings Co. has a 52 week low of $104.93 and a 52 week high of $146.36. The firm has a market cap of $4.38 billion, a price-to-earnings ratio of 37.39, a PEG ratio of 1.72 and a beta of 1.09.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The company had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same period last year, the firm earned $1.14 EPS. The firm's revenue for the quarter was up 7.3% compared to the same quarter last year. On average, sell-side analysts expect that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. StockNews.com cut Integer from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. KeyCorp reduced their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Benchmark lowered their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Raymond James upped their price target on Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, April 25th. Finally, Truist Financial set a $150.00 price objective on Integer and gave the company a "buy" rating in a research note on Friday, April 25th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $145.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.